kodex

Kodex

ICD-10-CM
Code

P04.11

Newborn affected by maternal antineoplastic chemotherapy

Copy Code Send Code

Hierarchy

  • P00-P96 Certain conditions originating in the perinatal period (P00-P96)
    • P00-P04 Newborn affected by maternal factors and by complications of pregnancy, labor, and delivery (P00-P04)
      • P04 Newborn affected by noxious substances transmitted via placenta or breast milk
        • P04.1 Newborn affected by other maternal medication
          • P04.11 Newborn affected by maternal antineoplastic chemotherapy
          • P04.12 Newborn affected by maternal cytotoxic drugs
          • P04.13 Newborn affected by maternal use of anticonvulsants
          • P04.14 Newborn affected by maternal use of opiates
          • P04.15 Newborn affected by maternal use of antidepressants
          • P04.16 Newborn affected by maternal use of amphetamines
          • P04.17 Newborn affected by maternal use of sedative-hypnotics
          • P04.18 Newborn affected by other maternal medication
          • P04.19 Newborn affected by maternal use of unspecified medication
          • P04.1A Newborn affected by maternal use of anxiolytics

Notes

P00-P04

  • These codes are for use when the listed maternal conditions are specified as the cause of confirmed morbidity or potential morbidity which have their origin in the perinatal period (before birth through the first 28 days after birth).

P00-P96

  • Codes from this chapter are for use on newborn records only, never on maternal records

Code First

P04.1

  • withdrawal symptoms from maternal use of drugs of addiction, if applicable (P96.1)
    • P96.1 Neonatal withdrawal symptoms from maternal use of drugs of addiction

P04

  • any current condition in newborn, if applicable

Includes

P04

  • nonteratogenic effects of substances transmitted via placenta

P00-P96

  • conditions that have their origin in the fetal or perinatal period (before birth through the first 28 days after birth) even if morbidity occurs later

Excludes 1

P04.1

  • Q86.2 Dysmorphism due to warfarin
  • Q86.1 Fetal hydantoin syndrome

Excludes 2

P04.1

  • maternal anesthesia and analgesia in pregnancy, labor and delivery (P04.0)
    • P04.0 Newborn affected by maternal anesthesia and analgesia in pregnancy, labor and delivery
  • maternal use of drugs of addiction (P04.4-)
    • P04.4 Newborn affected by maternal use of drugs of addiction

P04

  • congenital malformations (Q00-Q99)
    • Q00-Q99 Congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)
  • encounter for observation of newborn for suspected diseases and conditions ruled out (Z05.-)
    • Z05 Encounter for observation and evaluation of newborn for suspected diseases and conditions ruled out
  • neonatal jaundice from excessive hemolysis due to drugs or toxins transmitted from mother (P58.4)
    • P58.4 Neonatal jaundice due to drugs or toxins transmitted from mother or given to newborn
  • newborn in contact with and (suspected) exposures hazardous to health not transmitted via placenta or breast milk (Z77.-)
    • Z77 Other contact with and (suspected) exposures hazardous to health

P00-P96

  • Q00-Q99 Congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)
  • endocrine, nutritional and metabolic diseases (E00-E88)
  • S00-T88 Injury, poisoning and certain other consequences of external causes (S00-T88)
  • C00-D49 Neoplasms (C00-D49)
  • A33 Tetanus neonatorum

Related Terms